NASDAQ:ORIC | Cash Flow Statement | Oric Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$41.49M
2026-03-31-$35.77M-$32.44M$2,000.00-$17.98M$61.14M
2025-12-31-$30.51M-$22.48M$227,000.00$16.98M$1.5M
2025-09-30-$32.59M
2025-06-30-$36.36M
2025-03-31-$30.02M-$32.53M$387,000.00$22.45M$11,000.00
2024-12-31-$36.31M-$28.05M$219,000.00$42.66M$575,000.00
2024-09-30-$34.57M
2024-06-30-$31.96M
2024-03-31-$25.01M-$30.19M$218,000.00-$61.87M$125.03M
2023-12-31-$28.33M-$24.27M$57,000.00$20.96M$453,000.00
2023-09-30-$25.48M
2023-06-30-$22.94M
2023-03-31-$23.95M-$20.63M$310,000.00$12.78M$0.00
2022-12-31-$20.85M-$15.33M$287,000.00$28.3M$24.79M
2022-09-30-$24.83M
2022-06-30-$20.29M
2022-03-31-$23.16M-$22.72M$723,000.00-$90.66M$16,000.00
2021-12-31-$22.77M-$16.28M$389,000.00$351,000.00$813,000.00
2021-09-30-$18.43M
2021-06-30-$21.01M
2021-03-31-$16.51M-$14.9M$182,000.00$40.65M$16,000.00
2020-12-31-$28.26M-$17.83M$411,000.00-$91.26M$125.5M
2020-09-30-$25.55M
2020-06-30-$11.02M
2020-03-31-$8.87M-$8.28M$4,000.00$189,000.00-$1.63M
2019-12-31-$8.35M-$7.15M$56,000.00-$56,000.00-$61,000.00
2019-09-30-$6.55M
2019-06-30-$5.97M
2019-03-31-$6.02M-$5.53M$100,000.00-$100,000.00$15.26M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$129.47M-$110.97M$712,000.00-$148.03M$245.26M
2024-12-31-$127.85M-$112.66M$1.19M$22.14M$126.55M
2023-12-31-$100.7M-$85.69M$849,000.00-$43.4M$85.66M
2022-12-31-$89.12M-$75.14M$2.08M-$109.25M$25.23M
2021-12-31-$78.72M-$59.54M$939,000.00$158.44M$49.13M
2020-12-31-$73.7M-$45.27M$667,000.00-$215.96M$250.51M
2019-12-31-$26.88M-$23.53M$768,000.00-$768,000.00$70.82M
2018-12-31-$21.36M-$20.68M$525,000.00-$508,000.00$38.01M